Washington, D.C. – The American Clinical Laboratory Association (ACLA) today filed a notice of appeal in its lawsuit against the U.S. Department of Health and Human Services (HHS) challenging the agency’s implementation of the Protecting Access to Medicare Act (PAMA), which requires HHS to establish a market-based data collectiContinue Reading »
WASHINGTON, D.C.— In response to the Centers for Medicare and Medicaid Services’ (CMS) Final Decision Memo for Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer (CAG-00450R), ACLA President Julie Khani released the following statement: “We applaud CMS for making important changes to protect Medicare beneficiaContinue Reading »
An upcoming market-based system for pricing services performed by clinical laboratories is a “better alternative” for the industry than the current Medicare payment system, the president of the American Clinical Laboratory Association said April 23. Although many questions remain to be answered, the system to align Medicare payment rates witContinue Reading »
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) -- a not-for-profit association representing the nation's leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies –issued the following statement regarding the Clinical Continue Reading »
WASHINGTON, D.C. - In order to provide perspective and impact analysis for clinical laboratory professionals regarding a recently announced rule by the Centers for Medicare and Medicaid Services (CMS) that would allow consumers direct access to their lab results, the American Clinical Laboratory Association (ACLA) and G2 Intelligence, an organizaContinue Reading »
January 24, 2014 Mr. Marc Hartstein, Director Hospital and Ambulatory Policy Group Center for Medicare Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 31344 MoPathGapfillInquiries@cms.hhs.gov RE: Notification of Reconsideration Period – 2013 Gapfill Payment Amounts Dear Marc, Please accContinue Reading »
Jonathan Blum Principal Deputy Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Dear Mr. Blum: On behalf of the American Clinical Laboratory Association (“ACLA”), we are writing to express our strong objection to CMS’s recent action establishing a new reduced price for CPT code 81Continue Reading »
